You are not logged in.

The effects of treating male hypogonadism on couples' sexual desire and function

Conaglen, John V. and Conaglen, Helen M. 2009, The effects of treating male hypogonadism on couples' sexual desire and function, Journal of sexual medicine, vol. 6, no. 2, pp. 456-463, doi: 10.1111/j.1743-6109.2008.01043.x.

Attached Files
Name Description MIMEType Size Downloads

Title The effects of treating male hypogonadism on couples' sexual desire and function
Author(s) Conaglen, John V.
Conaglen, Helen M.
Journal name Journal of sexual medicine
Volume number 6
Issue number 2
Start page 456
End page 463
Publisher Wiley-Blackwell Publishing Ltd.
Place of publication Oxford, England
Publication date 2009-02
ISSN 1743-6095
1743-6109
Summary Introduction: Hypogonadism is a common endocrine condition characterized by low levels of testosterone (T) and marked by numerous symptoms, one of which is low sexual desire. Studies comparing T delivery systems have suggested that hypogonadal men’s partners may be at risk from exposure to T gels. Little other mention is found of the impact of hypogonadism and its treatment on a man’s partner and the couple’s sexual function.

Aim: To assess sexual desire and sexual function in hypogonadal men and their woman partners before and after treatment with T replacement therapy.

Methods
: Twenty-one hypogonadal men and 18 partners were recruited from a   tertiary endocrine clinic, and were compared with a control group of 20 eugonadal age-matched men and their partners. All men had baseline blood tests to confirm their status as hypogonadal or eugonadal, and hypogonadal men repeated tests at 3-month intervals. All participants completed the Sexual Desire Inventory (SDI) and sexual function questionnaires at baseline and at 3-month intervals until the hypogonadal men attained normal T levels.

Main Outcome Measures
: Pre- and post-treatment SDI and sexual function questionnaires were compared once T normalization was achieved. Between- and within-group comparisons were carried out.

Results: Pretreatment hypogonadal men recorded lower levels of sexual desire and function than controls, but significantly improved once hypogonadism was corrected. Eugonadal controls recorded no significant changes in either sexual desire or function during the study. Partners of the hypogonadal men reported no changes on the SDI, but significant improvements in sexual function as their partners recovered.

Conclusion: SDI and sexual function measures reflect sexual changes that  accompany rising serum T levels during correction of male hypogonadism. Women partners reported more satisfaction, less pain, and improved sexual function following the men’s treatment. Treatments affecting one partner potentially have important effects on the other.
Language eng
DOI 10.1111/j.1743-6109.2008.01043.x
Field of Research 110306 Endocrinology
Socio Economic Objective 920106 Endocrine Organs and Diseases (excl. Diabetes)
HERDC Research category C1.1 Refereed article in a scholarly journal
Copyright notice ©2008, International Society for Sexual Medicine
Persistent URL http://hdl.handle.net/10536/DRO/DU:30024901

Document type: Journal Article
Collection: School of Psychology
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 16 times in TR Web of Science
Scopus Citation Count Cited 13 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 349 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Fri, 05 Mar 2010, 10:10:13 EST by Sally Morrigan

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.